|
|
Volumn 1, Issue 9, 2002, Pages 663-664
|
|
Erectile-dysfunction therapies. Market indicators
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIS;
AMYL NITRATE;
AMYL NITRITE;
APOMORPHINE;
DOPAMINE;
ISOSORBIDE DINITRATE;
ISOSORBIDE MONONITRATE;
NIVIVA;
ORGANIC NITRATE;
PAPAVERINE;
PHENTOLAMINE;
PHENTOLAMINE MESYLATE;
PHOSPHODIESTERASE INHIBITOR;
PROSTAGLANDIN E1;
SEROTONIN AGONIST;
SILDENAFIL;
TADALAFIL;
TESTOSTERONE;
VARDENAFIL;
YOHIMBINE;
PIPERAZINE DERIVATIVE;
COLOR VISION DEFECT;
COST BENEFIT ANALYSIS;
DRUG CONTRAINDICATION;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG MARKETING;
DRUG MECHANISM;
EJACULATION DISORDER;
ERECTILE DYSFUNCTION;
FEMALE SEXUAL DYSFUNCTION;
FOOD DRUG INTERACTION;
HEADACHE;
HOT FLUSH;
HUMAN;
INDIGESTION;
MALE;
NAUSEA;
NOTE;
PAIN;
PENILE FIBROSIS;
PRIAPISM;
PRIORITY JOURNAL;
PSYCHOTHERAPY;
ADULT;
AGED;
ARTICLE;
COMPARATIVE STUDY;
ECONOMICS;
IMPOTENCE;
MIDDLE AGED;
UNITED STATES;
ADULT;
AGED;
HUMANS;
IMPOTENCE;
MALE;
MIDDLE AGED;
PHOSPHODIESTERASE INHIBITORS;
PIPERAZINES;
PSYCHOTHERAPY;
UNITED STATES;
|
|
EID: 0036715645
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd898 Document Type: Note |
|
Times cited : (21)
|
|
References (3)
|
